Early positive results were seen in a HNSCC patient whose EGFR and MET expressing tumor was transplanted into humanized patient-derived xenograft models and exposed to Pembrolizumab with Amivantamab. The gene discussed is MET; the disease is head and neck squamous cell carcinoma.